These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 21441256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.
    J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110
    [Abstract] [Full Text] [Related]

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
    Borghesi S, Hawkins MA, Tait D.
    Clin Oncol (R Coll Radiol); 2008 Apr 01; 20(3):221-6. PubMed ID: 18248970
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N, Morimoto J, Tanaka H, Ohira M, Noda E, Amano R, Inoue T, Yamada N, Yashiro M, Maeda K, Yamashita Y, Muguruma K, Sawada T, Hirakawa K.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(12):1997-9. PubMed ID: 20037303
    [Abstract] [Full Text] [Related]

  • 8. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
    Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, Ito H, Yamashita T.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):122-8. PubMed ID: 19327900
    [Abstract] [Full Text] [Related]

  • 9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas.
    Toh Y, Ohga T, Itoh S, Kabashima A, Yamamoto K, Adachi E, Sakaguchi Y, Okamura T, Hirata H.
    Anticancer Res; 2006 Dec 01; 26(3B):2487-91. PubMed ID: 16821637
    [Abstract] [Full Text] [Related]

  • 13. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.
    J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K, Shim YM.
    Ann Thorac Surg; 2005 Oct 15; 80(4):1170-5. PubMed ID: 16181835
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
    Bédard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R.
    Cancer; 2001 Jun 15; 91(12):2423-30. PubMed ID: 11413534
    [Abstract] [Full Text] [Related]

  • 20. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.